Peer-Reviewed Journal Details
Mandatory Fields
McKernan DP, Dennison U, Gaszner G, Cryan JF, Dinan TG
2011
August
Translational psychiatry
Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype.
Validated
Optional Fields
1
Low-grade peripheral inflammation is often present in psychotic patients. Toll-like receptors (TLRs) are pattern-recognition molecules that initiate inflammation. Our objective was to investigate the peripheral TLR activity in psychosis. Forty schizophrenia patients, twenty bipolar patients and forty healthy controls (HC) were recruited. Donated whole blood was cultured with TLR agonists for 24h. Cell supernatants were analysed using a multiplex enzyme-linked immunosorbent assay approach to measure IL-1, IL-6, IL-8 and tumour necrosis factor-a (TNFa). Plasma was analysed for cytokines, cortisol and acute phase proteins. Here, we show that selective TLR agonist-induced cytokine (IL-1, IL-6, IL-8 and TNFa) release is enhanced in stimulated whole blood from schizophrenia and bipolar patients compared with HC. An exaggerated release of IL-1, IL-6 and TNFa following treatment with the TLR2 agonist HKLM was detected in both disorders compared with controls. Enhanced TLR4-induced increases in IL-1 for both disorders coupled with TNFa increases for bipolar patients were observed. TLR8-induced increases in IL-1 for both disorders as well as IL-6 and TNFa increases for bipolar patients were detected. TLR9-induced increases in IL-8 for schizophrenia patients were also observed. No differences in TLR1, TLR3, TLR5, TLR6 or TLR7 activity were detected. Plasma levels of IL-6 were significantly elevated in bipolar patients while TNFa levels were significantly elevated in schizophrenia patients compared with controls. Plasma acute phase proteins were significantly elevated in bipolar patients. These data demonstrate that specific alterations in TLR agonist-mediated cytokine release contribute to the evidence of immune dysfunction in psychotic disorders.
10.1038/tp.2011.37
Grant Details